Lexicon Pharmaceuticals | LXRX - Marktkapitalisierung

Aktienkurs
2.34
Täglich Wechseln
0.34 16.75%
Monatlich
32.67%
Jährlich
233.10%
Q2 Prognose
1.96




Marktkapitalisierung Veränderung Datum
Abbott USD 178.41B 39.46B 2026-03
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 8.23B 313M 2026-05
Illumina USD 17.88B 2.74B 2026-03
Insmed USD 15.56B 19.73B 2026-05
J&J USD 579.15B 78.91B 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 102M 4M 2025-12
MannKind USD 965M 208M 2026-05
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Novartis USD 232.75B 75B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Sarepta Therapeutics USD 2.16B 123M 2026-05
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05
Vanda Pharmaceuticals USD 279M 6M 2024-12